Methylenetetrahydrofolate (MTHFR) gene polymorphisms are known to be associated with hyperhomocysteinemia; however, their influence on plasma homocysteine (Hcy), a risk factor for essential hypertension (EH), remains uncertain. We examined the association of four known polymorphisms of the MTHFR gene (C677T, A1298C, G1793A and T1317C) and their haplotypes with Hcy and EH. Plasma Hcy levels were significantly higher and folate levels were lower in patients compared with normotensive controls (Po0.05). No significant association was found between plasma Hcy and serum folate with any of the MTHFR genotypes. Two haplotypes, C-C-A-T and T-A-G-T, were found to be associated with 3.5-fold increased risk of EH as compared with individual genotypes.
The prevalence of hypertension in the North Indian population is high and varies between 22 and 29%. 1 Increased Plasma Hcy levels have been reported in Indian patients with EH. 2 Besides genetic factors, dietary factors such as low micronutrients (vitamin C, folic acid and zinc), which have been identified as predisposing factors for hypertension in vegetarian populations such as Indians may lead to Hhcy.
3 MTHFR 677TT and 1298CC genotypes have been shown to be associated with reduced MTHFR enzyme activity 4, 5 and increased Hcy levels.
2,4,5 Koupepidou et al. 6 proposed that MTHFR 677TT and 677CT/1298AC genotypes may be predisposing hypertensive patients to chronic renal failure. Recently, two more variants, MTHFR G1793A 7 and T1317C, 5 were identified in the MTHFR gene; G1793A polymorphism was found to be associated with decreased Hcy concentrations. 8 In this study, we evaluated the comprehensive effects of four MTHFR polymorphisms, C677T, A1298C, T1317C and G1793A, and their haplotypes on EH and plasma Hcy concentrations in an ethnically homogeneous North Indian cohort. Two hundred and eighty essential hypertensives diagnosed as per JNC VII guidelines were enrolled. Patients with a history of systemic, cardiovascular, renal diseases and diabetes mellitus were excluded from this study. Three blood pressure measurements in sitting position were taken using a mercury sphygmomanometer and the average of second and third measurements was recorded. Two hundred and fifty unrelated, age, sex and ethnicity-matched normotensives (systolic blood pressure/diastolic blood pressure o130/80 mm Hg) were enroled as controls. Patients and controls were ascertained to have at least both parents and grandparents born in Northern India to ensure homogeneous ethnicity. All patients provided written informed consent and the study was approved by the Institute Ethics Committee. Plasma Hcy and folate were measured by ELISA (Axis Shield Diagnostics, UK; AIA-PackFolate Assay Kit, Tosch Biosciences, Belgium). Genomic DNA was isolated and MTHFR C677T, 4 A1298C, 5 T1317C 5 and G1793A 7 were genotyped by PCR-restriction fragment length polymorphism. Data were analysed using Student's t-test and analysis of variance. Alleles were stratified into major and minor alleles for each single-nucleotide polymorphism and tested for deviations from the Hardy-Weinberg equilibrium. Genotypic associations and odds ratios (ORs) were estimated by binary logistic regression. One-way analysis of variance and post hoc test with Tukey's test was performed to estimate the relationship between Hcy and folate with the MTHFR genotypes. Haplotypes were generated by PHASE software. Linkage disequilibrium was estimated using Haploview software. (Figure 1) . The prevalence and severity of hypertension and Hcy or folate levels did not differ significantly across MTHFR genotypes (P40.05). Five major MTHFR haplotypes (41% frequency) were observed; the prevalence of haplotype C-A-T-G was significantly higher in controls compared with patients (Po0.001) and was associated with a decreased risk (OR ¼ 0.3; 95% CI ¼ 0.21-0.44). Frequencies of haplotypes C-A-G-C (OR ¼ 2.83; 95% CI: 1.25-6.43), C-C-A-T (OR ¼ 3.59; 95% CI: 0.95-13.79) and T-A-G-T (OR ¼ 3.65; 95% CI: 1.77-7.51) were significantly higher in patients compared with controls and were associated with increased risk of hypertension. One patient had a haplotype consisting of all mutant alleles. Linkage disequilibrium was not significant and was low across the studied single-nucleotide polymorphisms, ranging from D 0 ¼ 0.05-0.36. The salient finding of our study is that besides MTHFR C677T, A1298C and G1793A genotypes are also associated with EH. Haplotype analysis also yielded evidence for such a disease association. It can be noted that our results revealed three mutant alleles (677T or 1298C or 1317C) carrying haplotypes to be significantly associated with increased risk of EH and wild allele bearing haplotype to be associated with decreased risk of hypertension. Although mutant 677T and 1298C alleles independently also showed significant association with hypertension, 1317C allele was not discrepant between case and control subjects. The implication of a specific haplotype for risk of hypertension is clearly intriguing; one may speculate that risk haplotype defines a specific combination of genetic variations that control MTHFR gene expression. We observed low levels of disequilibrium between the studied single-nucleotide polymorphisms; thus, the chosen single-nucleotide polymorphisms provided incremental information on association between MTHFR genotypes and hypertension.
We found MTHFR G1793A mutant genotypes to be associated with increased risk of EH; however, we did not find any significant association of G1793A genotypes with Hcy levels. The frequency of mutant 1793AA genotype in our subjects was low and comparable to those reported by others. 7 There are conflicting reports regarding the association of MTHFR G1793A variants with cardiovascular disease or increased Hcy levels. 9 Currently, it is not known whether MTHFR G1793A affects the functional activity of enzyme. Similar to earlier studies in Caucasians, 10 we did not observe any significant association of mutant 1317CC with either hypertension or Hcy levels.
Increased folate levels in MTHFR 1793AA genotype have been reported earlier; 7 however, we did not observe any association of MTHFR genotypes with folate levels. This may be due to differences in the study groups and ethnicity.
Although plasma Hcy levels has been shown to be influenced by factors such as age, gender, folate, vitamin B-12 status, smoking and dietary factors, 11 we did not find any significant difference in Hcy levels based on age, gender and smoking habits in our study population.
This study has certain limitations. The subjects in our study were predominantly North Indian, which renders generalizability to other ethnic groups uncertain. Another limitation of our study is the medium size of our study sample and the lack of confirmation of our findings in another population. Although both points are valid, the scarcity of DNA collections from other case-control studies prevents us from replicating our findings. However, this study fulfils most of the criteria of a good genetic association study suggested by Hattersley et al. 12 Moreover, observation of an OR 42 for MTHFR genotypes/haplotypes and hypertension suggests an association of notably strong magnitude, which would be of interest to confirm in future studies. In conclusion, our data suggest a significant association between MTHFR polymorphisms and hypertension in North Indian subjects and indicate that the haplotype approach may be superior for risk stratification. However, these results need to be confirmed in a larger cohort and in other populations.
